ArticleCentral European journal of urology2026
Erectile and ejaculatory outcomes after HoLEP: A longitudinal analysis during the learning curve.
Article in Central European journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Holmium laser enucleation of the prostate (HoLEP) is a well-established surgical technique for benign prostatic obstruction. Although functional outcomes have been widely reported, data on sexual function during the learning phase remain limited. The aim of this study was to describe longitudinal erectile and ejaculatory outcomes during the initial learning curve of HoLEP. Material and methods: The first 254 consecutive patients undergoing HoLEP by a single surgeon were prospectively collected and retrospectively analyzed. Erectile function was evaluated using the Sexual Health Inventory for Men (SHIM) preoperatively and at 1, 3, 6, and 12 months. Ejaculatory function was assessed at the same intervals. Descriptive and comparative statistics were used, and patients were stratified into case groups to explore surgical experience impact. Results: A total of 254 patients were included. Mean patient age was 70.1 ±7.7 years and mean prostate volume was 90.9 ±34.4 cc. Preoperative SHIM scores were available for 222 patients, with a median of 12.7 [5.0-20.0]. SHIM decreased at 1 month (9 [3-15]) and recovered at 3 (12 [5-20]) and 6 months (13 [6-22]). At 12 months, erectile function remained stable (12 [5-20]) with no clinically relevant deterioration. Anejaculation was observed in 93.2% at 1 month and persisted throughout follow-up (>94%), with no significant differences across case groups. Conclusions: In this real-world HoLEP series, erectile function was preserved at mid-term follow-up, with a high and persistent rate of anejaculation. Sexual outcomes did not appear influenced by surgical experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.